Maxcyte Stock Odds of Future Stock Price Finishing Under 3.54
| MXCT Stock | USD 4.16 0.03 0.72% |
MaxCyte |
MaxCyte Target Price Odds to finish below 3.54
The tendency of MaxCyte Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 3.54 or more in 90 days |
| 4.16 | 90 days | 3.54 | about 19.09 |
Based on a normal probability distribution, the odds of MaxCyte to drop to $ 3.54 or more in 90 days from now is about 19.09 (This MaxCyte probability density function shows the probability of MaxCyte Stock to fall within a particular range of prices over 90 days) . Probability of MaxCyte price to stay between $ 3.54 and its current price of $4.16 at the end of the 90-day period is about 77.38 .
Given the investment horizon of 90 days MaxCyte has a beta of 0.88. This indicates MaxCyte market returns are related to returns on the market. As the market goes up or down, MaxCyte is expected to follow. Additionally MaxCyte has an alpha of 0.0933, implying that it can generate a 0.0933 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). MaxCyte Price Density |
| Price |
Predictive Modules for MaxCyte
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MaxCyte. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MaxCyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MaxCyte Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MaxCyte is not an exception. The market had few large corrections towards the MaxCyte's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MaxCyte, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MaxCyte within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.09 | |
β | Beta against Dow Jones | 0.88 | |
σ | Overall volatility | 0.23 | |
Ir | Information ratio | 0.02 |
MaxCyte Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MaxCyte for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MaxCyte can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MaxCyte had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 41.29 M. Net Loss for the year was (37.92 M) with profit before overhead, payroll, taxes, and interest of 39.16 M. | |
| MaxCyte currently holds about 240.89 M in cash with (21.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.37. | |
| Roughly 70.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Getting In Cheap On MaxCyte, Inc. Might Be Difficult |
MaxCyte Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MaxCyte Stock often depends not only on the future outlook of the current and potential MaxCyte's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MaxCyte's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 103.3 M | |
| Cash And Short Term Investments | 168.3 M |
MaxCyte Technical Analysis
MaxCyte's future price can be derived by breaking down and analyzing its technical indicators over time. MaxCyte Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MaxCyte. In general, you should focus on analyzing MaxCyte Stock price patterns and their correlations with different microeconomic environments and drivers.
MaxCyte Predictive Forecast Models
MaxCyte's time-series forecasting models is one of many MaxCyte's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MaxCyte's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about MaxCyte
Checking the ongoing alerts about MaxCyte for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MaxCyte help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| MaxCyte had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 41.29 M. Net Loss for the year was (37.92 M) with profit before overhead, payroll, taxes, and interest of 39.16 M. | |
| MaxCyte currently holds about 240.89 M in cash with (21.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.37. | |
| Roughly 70.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Getting In Cheap On MaxCyte, Inc. Might Be Difficult |
Additional Tools for MaxCyte Stock Analysis
When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.